Phase II study of brigatinib for ALK-positive advanced non-small cell lung cancer with untreated brain metastases (LOGIK2201: BRAVES)

JAAD International · Elsevier

Аннотация

Publication date: December 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 4 Author(s): Yoshiro Nakahara, Yoshimasa Shiraishi, Kohei Otsubo, Hiroaki Sakamoto, Hisashi Tanaka, Junji Koyama, Motohiro Tamiya, Kei Kunimasa, Yasutaka Watanabe, Takaaki Tokito, Hidenobu Ishii, Ryo Morita, Keisuke Kosai, Masafumi Yamaguchi, Yuki Takeyasu, Takayasu Kurata, Kei Morikawa, Naoki Furuya, Masahiro Shinmura, Kentaro Tanaka

Читать у издателя →

Похожие статьи